AR074674A1 - COMBINATION OF IMPROVED ACTIVE SUBSTANCES THAT INCLUDES AN ANTIBIOTICO AND AN NON-STEROID ANTI-INFLAMMATORY PHARMACO (NSAID) - Google Patents

COMBINATION OF IMPROVED ACTIVE SUBSTANCES THAT INCLUDES AN ANTIBIOTICO AND AN NON-STEROID ANTI-INFLAMMATORY PHARMACO (NSAID)

Info

Publication number
AR074674A1
AR074674A1 ARP090104888A ARP090104888A AR074674A1 AR 074674 A1 AR074674 A1 AR 074674A1 AR P090104888 A ARP090104888 A AR P090104888A AR P090104888 A ARP090104888 A AR P090104888A AR 074674 A1 AR074674 A1 AR 074674A1
Authority
AR
Argentina
Prior art keywords
inflammatory
combination
nsaid
antibiotico
pharmaco
Prior art date
Application number
ARP090104888A
Other languages
Spanish (es)
Inventor
Kristine Fraatz
Iris Heep
Stefan Hofmann
Martina Rehagen
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of AR074674A1 publication Critical patent/AR074674A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La solicitud se refiere a formulaciones de combinación novedosas en veterinaria que comprenden un antibiótico de quinolona y un fármaco antiinflamatorio no esteroideo (AINE). Las formulaciones, en particular las soluciones inyectables, que comprenden un antibiótico de quinolona y una sustancia antiinflamatoria son particularmente adecuadas para el tratamiento parenteral de infecciones bacterianas en animales, como por ejemplo, ganado vacuno, porcino, perros y gatos. Reivindicación 2: Combinación de acuerdo con la reivindicación 1, en la que el fármaco antiinflamatorio no esteroideo es ketoprofeno. Reivindicación 3: Combinación de acuerdo con una de las reivindicaciones precedentes, en la que el antibiótico de quinolona es enrofloxacino. Reivindicación 4: Uso de la combinación de acuerdo con una de las reivindicaciones precedentes para la preparación de fármacos para el tratamiento de enfermedades bacterianas.The application relates to novel veterinary combination formulations comprising a quinolone antibiotic and a non-steroidal anti-inflammatory drug (NSAID). The formulations, in particular the injectable solutions, comprising a quinolone antibiotic and an anti-inflammatory substance are particularly suitable for parenteral treatment of bacterial infections in animals, such as cattle, pigs, dogs and cats. Claim 2: Combination according to claim 1, wherein the non-steroidal anti-inflammatory drug is ketoprofen. Claim 3: Combination according to one of the preceding claims, wherein the quinolone antibiotic is enrofloxacin. Claim 4: Use of the combination according to one of the preceding claims for the preparation of drugs for the treatment of bacterial diseases.

ARP090104888A 2008-12-18 2009-12-15 COMBINATION OF IMPROVED ACTIVE SUBSTANCES THAT INCLUDES AN ANTIBIOTICO AND AN NON-STEROID ANTI-INFLAMMATORY PHARMACO (NSAID) AR074674A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102008063726 2008-12-18

Publications (1)

Publication Number Publication Date
AR074674A1 true AR074674A1 (en) 2011-02-02

Family

ID=41683035

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090104888A AR074674A1 (en) 2008-12-18 2009-12-15 COMBINATION OF IMPROVED ACTIVE SUBSTANCES THAT INCLUDES AN ANTIBIOTICO AND AN NON-STEROID ANTI-INFLAMMATORY PHARMACO (NSAID)

Country Status (2)

Country Link
AR (1) AR074674A1 (en)
WO (1) WO2010069493A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2480276A (en) * 2010-05-11 2011-11-16 Michael Hilary Burke Process for the preparation of an aqueous injectable enrofloxacin antimicrobial formulation
CN110327348A (en) * 2019-07-19 2019-10-15 余祖功 Compound long-acting injection and preparation method thereof containing Enrofloxacin and Meloxicam

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10337191A1 (en) * 2003-08-13 2005-03-17 Bayer Healthcare Ag New use of quinolone antibiotics
DE102006010642A1 (en) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Drug formulations containing fluoroquinolones
DE102006010643A1 (en) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Using quaternary ammonium compounds to inhibit precipitation of fluoroquinolone antibiotics, particularly in ready-for-use formulations for veterinary medicine

Also Published As

Publication number Publication date
WO2010069493A1 (en) 2010-06-24

Similar Documents

Publication Publication Date Title
GT201000160A (en) AMINOBENZAMIDE DERIVATIVES AS USEFUL AGENTS FOR THE CONTROL OF PARASITES OF ANIMALS
CL2014002087A1 (en) Chewable veterinary composition comprising as active agent an isoxazoline derivative compound; and its use for the treatment and / or prevention of an infestation and / or infection by parasites in an animal.
CL2012002764A1 (en) Liquid veterinary composition comprising fipronil, praziquantel, an active growth regulating agent, amervectin or milbemycin, a vehicle, and optionally a crystallization inhibitor; and its use for the treatment or prevention of a parasitic infection or infestation.
ECSP056074A (en) COMPOSITIONS AND METHOD TO TREAT MICROBIAL AND PARASITARY INFECTIONS IN LIVESTOCK AND OTHER ANIMALS
BRPI0512274A (en) aryl-substituted piperazine derivatives
BRPI0813450A2 (en) COMPOUND, COMPOSITION, COMBINATION, PHARMACEUTICAL FORMULATION, AND METHODS TO INHIBIT AN ENZYME, TO EXTERMINE OR PREVENT GROWTH OF A MICROORGANISM, AND TO TREAT AND / OR PREVENT A DISEASE IN AN ANIMAL
AR048718A1 (en) USE OF MELOXICAM FORMULATIONS IN VETERINARY MEDICINE
UY30587A1 (en) BENZOXAZOLES AND OXAZOLOPIRIDINES THAT ARE USEFUL AS INHIBITORS OF THE S JANUS CINASES
AR054987A1 (en) TRASMUCOSAL VETERINARY COMPOSITION
AR058679A1 (en) PHARMACEUTICAL PREPARATION CONTAINING MELOXICAM
AR080721A1 (en) 1 - ((3-CIANO-PIRIDIN-2-IL) METHYL] -3-METIL-7- (2-BUTIN-1-IL) -8- (3- (R) - AMINO-PIPERIDIN-1-IL) - XANTINA FOR TREATMENT OF A METABOLIC DISORDER OF A NON-HUMAN ANIMAL PREDOMINANTLY CARNIVOROUS
BRPI1006957A2 (en) animal feed suitable for feeding mammals, birds and fish, ingredient, premix or supplement for animal feed suitable for feeding mammals, birds and fish, method for increasing feed efficiency and / or reducing the risk of infections in a livestock. creation, and use of an alkyl ester or an alkyl ester enriched product.
ITMI20021427A1 (en) COMPOSITIONS FOR USE IN ANIMAL FEEDING INCLUDING A CONTROLLED RELEASE DIE PREPARATION PROCEDURE AND RELATED APPLICATIONS
UY30640A1 (en) COMPOUNDS
AR048342A1 (en) PHARMACEUTICAL DOSAGE FORMS THAT INCLUDE THE N- (2- (2-FTHALIMIDOETOXI) -ACETILE) -L-ALANIL-D-GLUTAMIC ACID (LK-423)
BR112015006568A2 (en) lactic acid bacteria and compositions
BRPI0807285A2 (en) "COMPOSITION, METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION, UNIT FORM OF DOSAGE, METHOD FOR ADMINISTRATING A BIOLOGICAL ACTIVE AGENT NEEDING THE AGENT, METHOD FOR INCREASING BIODISPONABILITY FOR PREPARING AN AGENT OF COMPOSITION"
UY30790A1 (en) COMBINATION OF TWO ANTIPARASITARY AGENTS, IN PARTICULAR A DERIVATIVE OF 1-ARIL-4-CICLOPROPILPIRAZOL AND AN ANTIHELMINTIC AGENT AND APPLICATIONS
MA29453B1 (en) SYNERGISTIC ASSOCIATIONS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS WITH ALPHA-2-DELTA LIGANDS
AR074674A1 (en) COMBINATION OF IMPROVED ACTIVE SUBSTANCES THAT INCLUDES AN ANTIBIOTICO AND AN NON-STEROID ANTI-INFLAMMATORY PHARMACO (NSAID)
NI200800167A (en) VETERINARY COMPOSITION COMPOSED OF ORGANIC LEVAMISOL SALT COMBINED WITH AT LEAST ONE AVERMECTIN AND / OR MILBEMYCIN.
AR051429A1 (en) OZONIZED PHARMACEUTICAL COMPOSITION AND METHODS TO OBTAIN IT
CL2009000987A1 (en) Feed composition comprising peptidoglycan and nucleotides; and its use for the prophylaxis and / or treatment of infectious diseases in animals.
BR112016007057A2 (en) a veterinary method to induce emesis
AR075543A1 (en) PROCESS FOR APPLICATION OF ANTIBIOTICS AND FOR APPLICATION OF AGENTS OF FUNCTION CONTROL OF MICROORGANISM BACTERIA AND OTHER BEING CAUSES OF DISEASES IN ANIMALS

Legal Events

Date Code Title Description
FB Suspension of granting procedure